MARC2 antibody (C-Term)
MARC2
Reactivity: Human
WB, IHC (p), FACS
Host: Rabbit
Polyclonal
RB22590
unconjugated
-
- Target See all MARC2 Antibodies
- MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))
-
Binding Specificity
- AA 270-300, C-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This MARC2 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This MOSC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 270-300 amino acids from the C-terminal region of human MOSC2.
- Clone
- RB22590
- Isotype
- Ig Fraction
-
anti-Mitochondrial Amidoxime Reducing Component 2 (MARC2) (AA 304-333), (C-Term) antibody
MARC2 Reactivity: Mouse WB Host: Rabbit Polyclonal RB32566 unconjugated
-
- Application Notes
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Expiry Date
- 6 months
-
- Target
- MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))
- Alternative Name
- MOSC2 (MARC2 Products)
- Synonyms
- MOSC2 antibody, RP11-270A6.1 antibody, 2810484M10Rik antibody, Mosc2 antibody, mARC1 antibody, Mg87 antibody, mARC2 antibody, mitochondrial amidoxime reducing component 1 antibody, mitochondrial amidoxime reducing component 2 antibody, MARC1 antibody, MARC2 antibody, Marc2 antibody
- Background
- Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.
- Molecular Weight
- 38023
- Gene ID
- 54996
- NCBI Accession
- NP_060368
- UniProt
- Q969Z3
-
You are here:
